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A gene encoding cystatin a has been chemically synthesized, cloned and expressed in E. coli. The gene of 318 base pairs 
was assembled by enzymatic ligation of 19 oligonucleotides and cloned into a pBR322-derived expression plasmid down 
stream of the tat promoter. The expression product of the synthetic gene has been purified by Sephadex G-SO column 
chromatography and shown to have the same properties as those of the authentic protein isolated from rat epidermis. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Cystatin u is one of the specific endogenous in- 
hibitors of cysteine proteinases and a member of 
the evolutionary superfamily [I]. Cystatin LY, with 
an M, of about 11000, lacks cysteinyl residues and 
shows limited distribution in epidermis, squamous 
epithelia and neutrophils [2,3]. 
2.1. Design of the gene 
A new method for the large scale production of 
cystatin LY using recombinant DNA technology has 
been developed to study the relationship between 
structure and inhibitory activity using X-ray 
crystallography, and also to develop new drugs of 
therapeutic use for specified diseases based on ab- 
normal increase of cysteine proteinases such as 
muscular dystrophy [4], distal myopathy [5] as well 
as for the suppression of proliferation of some 
RNA viruses [6]. This paper deals with the total 
synthesis of the cystatin cy gene, its expression in E. 
coli and purification of the product. 
Based on the amino acid sequence of cystatin cy (71, 19 
overlapping oligonucleotide fragments were designed according 
to the codon usage of E. coli [8] as shown in fig. 1. The recogni- 
tion sites of EcoRI and BumHI were placed at the 5’- and 
3 ‘-ends of the gene, respectively. As the N-terminal amino acid 
of cystatin cy is methionine, an additional codon for it was un- 
necessary for the initiation of translation. Tandem translation 
stop codon was incorporated at the C-terminal. 
2.2. Chemical synthesis of the oligomers 
The 19 oligomers were synthesized by the phosphoramidite 
method [9] using an automatic DNA synthesizer (Microsyn 
1450A). The product was removed from the solid support and 
purified by polyacrylamide gel electrophoresis (PAGE). The 
product band was detected by UV light, cut out, eluted and 
precipitated from ethanol. 
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2.3. Assembly of the gene fragments and its cloning in E. coli 
The assembly was performed as shown in fig.2. The 
fragments 1, 2, 11, 12 and 13 were mixed and phosphorylated. 
After annealing, the mixture was ligated to make segment A. 
Segment A was then purified by PAGE and DE-52 cellulose col- 
umn chromatography. Other segments B, C and D were 
prepared in the same manner. Segments A and B (C and D) 
were ligated to segment AB (CD), which was purified by 
PAGE. Segments AB and CD were ligated to construct he total 
gene of cystatin (Y. The resulting gene was purified by extraction 
with phenol/chloroform followed by ethanol precipitation. The 
chemically and biochemically synthesized cystatin cr gene was 
then ligated to pBR322 previously digested with EcoRI and 
BumHI. The plasmid was introduced into E. coli MC1061 and 
the resulting ampicillin-resistant transformants were screened 
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Fig. 1. Design of synthetic gene fragments based on the amino acid sequence of cystatin cy. The recognition sites of EcoRI and BumHI 
were placed at the 5 ‘- and 3 ’ -ends of the gene, respectively. Tandem translation stop codon was inserted at the 3 ‘-end. 
by hybridization to radiolabeled oligomer fragment 1 and frag- 
ment 20. Restriction enzyme analysis revealed that five of eight 
hybridization positive transformants contained the desired 
EcoRI-BumHI fragment corresponding to the synthetic gene of 
cystatin (Y. The nucleotide sequence of the fragment was con- 
firmed by the method of Maxam and Gilbert. 
2.4. Expression of cystatin a gene in E. coli 
The EcoRI-Hind111 fragment of pTPI-010 containing the 
EcoRI-BumHI fragment was ligated to the E. coli tat expres- 
sion plasmid (pKK223-3) [lo] at the EcoRI and Hind111 sites 
(fig.3). The resulting plasmid was introduced into E. coli 
MC1061. Transformants were screened by the same method as 
mentioned above. One of the positive transformants, E204, was 
employed for the purification of cystatin cr. 
2.5. Culture of (I recombinant strain of E. coli 
The recombinant strain E204 was grown at 37°C for 16 h in 
L-broth (1% tryptone, 0.5% yeast extract (Difco), 1% NaCl 
and 30pg/ml ampicillin). The cells were harvested by cen- 
trifugation at 10000 x g for 30 min. 
2.6. Purification of cystatin LY from E. coli 
Harvested cells were frozen and thawed twice and suspended 
in 5 vols of 25 mM Tris-HCl buffer, pH 7.5, containing 1 mM 
EDTA. The suspension was vortex-mixed for 30 s and cen- 
trifuged at 10000 x g for 10 min at 4°C. The supernatant was 
then applied to a column of Sephadex G-50 equilibrated with 
25 mM Tris-HCl buffer, pH 7.5, containing 0.15 M NaCl and 
eluted with the same buffer. Cystatin cy fractions were pooled, 
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Fig.2. Construction of a plasmid containing chemically 
synthesized cystatin cy gene. 
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Fig.3. Construction of a plasmid for the expression of cystatin 
cy gene under tat promoter control. 
concentrated by ultrafiltration using a YM-10 membrane and 
dialyzed overnight against 10 mM Tris-HCl buffer, pH 8.0. The 
dialysate was further purified on a column of DE-52 with the 
gradient elution of O-O.2 M NaCl in 10 mM Tris-HCl buffer, 
pH 8.0. Cystatin LY fractions were pooled. Amino acid analysis 
of the purified cystatin LY was performed as described previously 
131. 
3. RESULTS AND DISCUSSION 
3.1. Purification of cystatin LY 
Cystatin cy can be solubilized easily from recom- 
binant E. coli by freezing and thawing, and by 
following extraction with buffer. Sephadex G-50 
column chromatography proved to be very useful 
in the next process. By further purification with 
DE-52, it gave a single band on SDS-PAGE (not 
shown). The best overall yield was 20 mg of pro- 
tein from 1 g of wet cells. Though only E204 strain 
is referred to in this paper, better recombinant 
strains producing higher amounts of the inhibitor 
are now constructed by improving the expression 
system of the plasmid. Strain improvement for the 
secretion of cystatin (Y remains to be studied. 
3.2. Properties of recombinant ype cystatin cr 
The purified recombinant cystatin LY inhibited 
papain and cathepsins B, H and L to the same ex- 
tent as the naturally-occurring counterpart. The 
cystatin LY showed the same mobility on the elec- 
trophorsis in the presence and absence of SDS and 
also reacted with the antiserum against he natural 
one (not shown). The amino acid composition of 
the recombinant cystatin cy is shown in table 1. It 
is in good agreement with that of rat cystatin LY [7]. 
These results demonstrate that both cystatins are 
identical to each other. Our studies have made 
possible the supply of cystatin (Y in quantities large 
enough to use in studying its therapeutic effec- 
tiveness and biological functions as well. 
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